Background. Toxicities observed with current combination antiretroviral therapy (CART) warrant a search for novel options, such as class-sparing regimens.

• 背景：当前联合抗逆转录病毒疗法（CART）中观察到的毒性作用促使人们寻求新的选择，例如药物缩减疗法。